Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Glucagon-like peptide-1 (GLP-1) is a hormone that regulates the reward response in this complex pathway. GLP-1 hormones interact with receptors in multiple brain regions to induce various ...

The other pathway is that GLP-1 receptors located all over the body in places like the brain are responsible for impulse control and reward signaling, which may be why the medications work to ...

The studies using animal research showed that GLP-1 drugs helped reduce cravings for several substances by affecting dopamine pathways. Some of the substances tested include alcohol, nicotine, cocaine ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

CagriSema from Novo Nordisk activates both GLP-1 and amylin receptors. It is currently the subject of several clinical trials ...

innovations such as GLP-1 Elevate are being recognized for their potential to provide a natural, drug-free pathway to achieving weight loss goals. The unique formulation of GLP-1 Elevate promotes ...

Hims & Hers Health (HIMS) has seen its shares decline over 17% in the past week since the U.S. Food and Drug Administration ...

The studies using animal research showed that GLP-1 drugs helped reduce cravings for several substances by affecting dopamine pathways. Some of the substances tested include alcohol, nicotine ...